Tianli Pharmaceutical
Tianli Pharmaceutical Co., Ltd., commonly referred to as Tianli Pharma, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in the early 2000s, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, particularly in the fields of traditional Chinese medicine and modern therapeutics. With a strong operational presence across various regions in Asia, Tianli Pharma focuses on innovative drug formulations and health supplements that cater to diverse medical needs. Their core offerings include herbal extracts and prescription medications, distinguished by their commitment to quality and efficacy. Recognised for its robust research and development capabilities, Tianli Pharmaceutical has positioned itself as a trusted name in the market, achieving notable milestones in product approvals and international collaborations.
DitchCarbon Score
How does Tianli Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tianli Pharmaceutical's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Tianli Pharmaceutical's reported carbon emissions
In 2019, Tianli Pharmaceutical reported total carbon emissions of approximately 21,728,600 kg CO2e from Scope 2 and about 109,740 kg CO2e from Scope 1. This marked an increase in emissions compared to 2018, where the company recorded approximately 28,188,870 kg CO2e in Scope 2 and about 85,640 kg CO2e in Scope 1. Despite these figures, there are currently no publicly disclosed reduction targets or climate pledges from Tianli Pharmaceutical. The absence of specific initiatives or commitments highlights a potential area for improvement in their environmental strategy. As the pharmaceutical industry increasingly focuses on sustainability, Tianli's lack of defined climate commitments may impact its competitive positioning in a market that values environmental responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2018 | 2019 | |
|---|---|---|
| Scope 1 | 85,640 | 000,000 |
| Scope 2 | 28,188,870 | 00,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tianli Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
